Tara Haelle (@TaraHaelle) is AHCJ's medical studies core topic leader, guiding journalists through the jargon-filled shorthand of science and research and enabling them to translate the evidence into accurate information.
Most of the time, the most important aspect of reporting on medical research is ensuring that the coverage is accurate, precise, clear and understandable to the average reader, and includes adequate context, including cost, side effects, alternative treatments and previous data. Other times, the medium, or, rather, the literal physical setting and the framing surrounding the message, matter as much or more, as some have argued regarding Anthony Fauci’s recent announcement about the NIH trial findings on remdesivir from the Oval Office couch.
But, as Gary Schwitzer points out in his most recent blog post at HealthNewsReview.com, other details can be utterly crucial to the public’s understanding about potentially important findings about a drug, particularly during a pandemic: What a particular study was intended to do in the first place. Continue reading →
Joseph Burns, a Massachusetts-based independent journalist, is AHCJ’s topic leader on health insurance. Bara Vaida is AHCJ's topic leader on infectious diseases. Her work has appeared in outlets that include MSNBC, NPR, Politico and The Washington Post.
The just-passed multibillion-dollar Families First Coronavirus Response Act includes free diagnostic testing for the new COVID-19 illness — for those fortunate enough to get a test if needed. The law also includes paid sick leave, nutrition assistance and boosts unemployment benefits for Americans out of work due to the pandemic, as Barbara Sprunt reported for NPR.
President Trump signed the bill into law after the U.S. Senate passed it on Wednesday. The House of Representatives had approved it the previous week. Continue reading →
Bara Vaida (@barav) is AHCJ's core topic leader on infectious diseases. An independent journalist, she has written extensively about health policy and infectious diseases. Her work has appeared in the National Journal, Agence France-Presse, Bloomberg News, McClatchy News Service, MSNBC, NPR, Politico, The Washington Post and other outlets.
An inaccurate statement that President Trump made during a March 19 news briefing — that the malaria drug hydroxychloroquine had been approved as a COVID-19 treatment — demonstrates how skeptical journalists should remain when covering the unfolding story about treatments and preventative measures.
Mary Otto, a Washington, D.C.-based freelancer, is AHCJ's topic leader on oral health and the author of "Teeth: The Story of Beauty, Inequality, and the Struggle for Oral Health in America." She can be reached at firstname.lastname@example.org.
Liz Seegert (@lseegert), is AHCJ’s topic leader on aging. Her work has appeared in NextAvenue.com, Journal of Active Aging, Cancer Today, Kaiser Health News and other outlets. She is a senior fellow at the Center for Health Policy and Media Engagement at George Washington University and co-produces the HealthCetera podcast.
Cancer diagnosis and care are complex. When comorbid conditions, multiple medications, changing physiology and decreasing resilience are involved, they present further challenges for many patients and their cancer specialists. How can they treat a serious disease while minimizing the risk of mortality, side effects, and diminished quality of life?
The good news is that people generally are living longer. The downside is that with increased longevity comes increased odds of developing various forms of cancer. Continue reading →